GLPwatch
Trials (2167)
Page 3 of 37.
- Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
- A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
- A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
- Trial of Exenatide for Parkinson's Disease
- Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
- GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)
- Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
- Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
- The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
- GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
- Feasibility of Semaglutide in Advanced Lung Disease
- Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
- Effects of Insulin Glargine and Lixisenatide on the Brain
- MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
- A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
- A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
- A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
- Antidiabetic Effects on Intrahepatic Fat
- Tirzepatide for Obesity and Meth Use Disorder
- SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Effect of Tirzepatide on Brown Adipose Tissue in Obesity
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
- Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
- Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
- A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
- Liraglutide in Adolescents With Type 1 Diabetes
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
- Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
- A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
- Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
- Semaglutide 2.4 mg in Patients With Poor Weight-loss
- Glutide for Ending Methamphetamine
- An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
- Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
- The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
- Basal Plus GLP1-ra on Glycemic Variability in CKD
- Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice
- Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data
- LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
- Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
- Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
- Clinical Trial for PB-119 in Healthy Subjects (Phase I)
- A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes
- Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
- Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
- Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes